JP2023535035A5 - - Google Patents
Info
- Publication number
- JP2023535035A5 JP2023535035A5 JP2023504356A JP2023504356A JP2023535035A5 JP 2023535035 A5 JP2023535035 A5 JP 2023535035A5 JP 2023504356 A JP2023504356 A JP 2023504356A JP 2023504356 A JP2023504356 A JP 2023504356A JP 2023535035 A5 JP2023535035 A5 JP 2023535035A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010713637 | 2020-07-22 | ||
| CN202010713637.0 | 2020-07-22 | ||
| PCT/CN2021/107575 WO2022017412A1 (zh) | 2020-07-22 | 2021-07-21 | 治疗造血干细胞移植后的移植物抗宿主病的方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023535035A JP2023535035A (ja) | 2023-08-15 |
| JPWO2022017412A5 JPWO2022017412A5 (https=) | 2024-07-29 |
| JP2023535035A5 true JP2023535035A5 (https=) | 2024-07-29 |
| JP7803924B2 JP7803924B2 (ja) | 2026-01-21 |
Family
ID=79728482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504356A Active JP7803924B2 (ja) | 2020-07-22 | 2021-07-21 | 造血幹細胞移植によって引き起こされる移植片対宿主病を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230285393A1 (https=) |
| EP (1) | EP4186508A4 (https=) |
| JP (1) | JP7803924B2 (https=) |
| KR (1) | KR20230043891A (https=) |
| CN (2) | CN121846099A (https=) |
| AU (1) | AU2021313124A1 (https=) |
| BR (1) | BR112023001049A2 (https=) |
| CA (1) | CA3186564A1 (https=) |
| IL (1) | IL299985A (https=) |
| TW (2) | TW202216691A (https=) |
| WO (1) | WO2022017412A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL311447A (en) * | 2021-09-18 | 2024-05-01 | Beijing Tide Pharmaceutical Co Ltd | A solid form of a Rho-linked protein kinase inhibitor or a solvate thereof, a method of preparation and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120202793A1 (en) * | 2009-03-09 | 2012-08-09 | Paul Sweetnam | Rho kinase inhibitors |
| CN113620933A (zh) * | 2012-10-05 | 2021-11-09 | 卡德门企业有限公司 | Rho激酶抑制剂 |
| WO2018039539A1 (en) * | 2016-08-26 | 2018-03-01 | Lycera Corporation | Indazolyl-l,2,4-thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease |
| CN110582489B (zh) | 2017-06-30 | 2023-10-27 | 北京泰德制药股份有限公司 | Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途 |
| WO2019000682A1 (zh) * | 2017-06-30 | 2019-01-03 | 北京泰德制药股份有限公司 | Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途 |
| US10323023B2 (en) * | 2017-06-30 | 2019-06-18 | Beijing Tide Pharmaceutical Co., Ltd. | Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof |
| TWI818919B (zh) * | 2017-08-15 | 2023-10-21 | 美商歐米諾斯公司 | 用於治療和／ 或預防與造血幹細胞移植有關的移植物抗宿主病和／ 或瀰漫性肺泡出血和／ 或靜脈閉塞性病的方法 |
-
2021
- 2021-07-21 AU AU2021313124A patent/AU2021313124A1/en active Pending
- 2021-07-21 CN CN202610271426.3A patent/CN121846099A/zh active Pending
- 2021-07-21 CA CA3186564A patent/CA3186564A1/en active Pending
- 2021-07-21 TW TW110126814A patent/TW202216691A/zh unknown
- 2021-07-21 BR BR112023001049A patent/BR112023001049A2/pt unknown
- 2021-07-21 EP EP21845732.3A patent/EP4186508A4/en active Pending
- 2021-07-21 IL IL299985A patent/IL299985A/en unknown
- 2021-07-21 JP JP2023504356A patent/JP7803924B2/ja active Active
- 2021-07-21 WO PCT/CN2021/107575 patent/WO2022017412A1/zh not_active Ceased
- 2021-07-21 US US18/017,198 patent/US20230285393A1/en active Pending
- 2021-07-21 TW TW112113471A patent/TWI868660B/zh active
- 2021-07-21 CN CN202180059344.8A patent/CN116322670A/zh active Pending
- 2021-07-21 KR KR1020237005450A patent/KR20230043891A/ko active Pending